Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall

U.S. Big Pharma Pfizer and German biotech partner BioNTech are looking to ramp up trials of vaccines against COVID-19 with a major scaled-up test plotted for the fall.

This is according to Pfizer’s CEO and chair Albert Bourla, talking to CNBC. Pfizer penned a deal with messenger RNA biotech BioNTech a few weeks back for them to work on a COVID-19 vaccine using new mRNA tech.